DK0699103T3 - Overflademodificerede, biokompatible membraner - Google Patents

Overflademodificerede, biokompatible membraner

Info

Publication number
DK0699103T3
DK0699103T3 DK94916437T DK94916437T DK0699103T3 DK 0699103 T3 DK0699103 T3 DK 0699103T3 DK 94916437 T DK94916437 T DK 94916437T DK 94916437 T DK94916437 T DK 94916437T DK 0699103 T3 DK0699103 T3 DK 0699103T3
Authority
DK
Denmark
Prior art keywords
pct
modified
biocompatible membranes
sec
date
Prior art date
Application number
DK94916437T
Other languages
English (en)
Inventor
Olle Larm
Elisabeth Scholander
Andrzej Werynski
Andrzej Joezwlak
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Application granted granted Critical
Publication of DK0699103T3 publication Critical patent/DK0699103T3/da

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
    • B01D67/0081—After-treatment of organic or inorganic membranes
    • B01D67/0093—Chemical modification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0029—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using an intermediate layer of polymer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
    • B01D67/0002—Organic membrane manufacture
    • B01D67/0009—Organic membrane manufacture by phase separation, sol-gel transition, evaporation or solvent quenching
    • B01D67/0011—Casting solutions therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
    • B01D67/0002—Organic membrane manufacture
    • B01D67/0009—Organic membrane manufacture by phase separation, sol-gel transition, evaporation or solvent quenching
    • B01D67/0016—Coagulation
    • B01D67/00165—Composition of the coagulation baths
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2323/00—Details relating to membrane preparation
    • B01D2323/08—Specific temperatures applied
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2323/00—Details relating to membrane preparation
    • B01D2323/12—Specific ratios of components used

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Manufacturing & Machinery (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Materials For Medical Uses (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Reciprocating, Oscillating Or Vibrating Motors (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
DK94916437T 1993-05-19 1994-05-09 Overflademodificerede, biokompatible membraner DK0699103T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO931809A NO931809L (no) 1993-05-19 1993-05-19 Hemofilter
PCT/NO1994/000088 WO1994026399A1 (en) 1993-05-19 1994-05-09 Surface modified biocompatible membranes

Publications (1)

Publication Number Publication Date
DK0699103T3 true DK0699103T3 (da) 2004-04-05

Family

ID=19896100

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94916437T DK0699103T3 (da) 1993-05-19 1994-05-09 Overflademodificerede, biokompatible membraner

Country Status (14)

Country Link
US (1) US5840190A (da)
EP (1) EP0699103B1 (da)
JP (1) JPH08510166A (da)
AT (1) ATE254953T1 (da)
AU (1) AU672708B2 (da)
BR (1) BR9406410A (da)
CA (1) CA2162495A1 (da)
DE (1) DE69433356T2 (da)
DK (1) DK0699103T3 (da)
ES (1) ES2211881T3 (da)
FI (1) FI955525A7 (da)
NO (1) NO931809L (da)
PT (1) PT699103E (da)
WO (1) WO1994026399A1 (da)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304220A (en) * 1991-07-03 1994-04-19 Maginot Thomas J Method and apparatus for implanting a graft prosthesis in the body of a patient
US20020156523A1 (en) * 1994-08-31 2002-10-24 Lilip Lau Exterior supported self-expanding stent-graft
US6331188B1 (en) * 1994-08-31 2001-12-18 Gore Enterprise Holdings, Inc. Exterior supported self-expanding stent-graft
DE19514104C2 (de) * 1995-04-13 1997-05-28 Behringwerke Ag Beschichtung für in den Blutstrom oder in das Gewebe des menschlichen Körpers einbringbares Biomaterial
EP0910309B1 (en) * 1996-06-20 2005-02-02 Vascutek Limited Prosthetic repair of body passages
US6551350B1 (en) * 1996-12-23 2003-04-22 Gore Enterprise Holdings, Inc. Kink resistant bifurcated prosthesis
FR2772639B1 (fr) 1997-12-24 2000-02-04 Hospal Ind Utilisation d'un polymere neutre ou cationique pour prevenir l'activation de la phase contact du sang ou du plasma en contact avec une membrane semi-permeable
US6221425B1 (en) * 1998-01-30 2001-04-24 Advanced Cardiovascular Systems, Inc. Lubricious hydrophilic coating for an intracorporeal medical device
KR20010020807A (ko) 1999-05-03 2001-03-15 조셉 제이. 스위니 고정 연마재 제품을 사전-조절하는 방법
FR2804328B1 (fr) * 2000-01-27 2002-03-15 Hospal Ind Membrane semi-permeable non thrombogene et procede de fabrication
US6848970B2 (en) 2002-09-16 2005-02-01 Applied Materials, Inc. Process control in electrochemically assisted planarization
US7125477B2 (en) 2000-02-17 2006-10-24 Applied Materials, Inc. Contacts for electrochemical processing
US6962524B2 (en) 2000-02-17 2005-11-08 Applied Materials, Inc. Conductive polishing article for electrochemical mechanical polishing
US7066800B2 (en) 2000-02-17 2006-06-27 Applied Materials Inc. Conductive polishing article for electrochemical mechanical polishing
US7077721B2 (en) 2000-02-17 2006-07-18 Applied Materials, Inc. Pad assembly for electrochemical mechanical processing
US7678245B2 (en) 2000-02-17 2010-03-16 Applied Materials, Inc. Method and apparatus for electrochemical mechanical processing
US7670468B2 (en) 2000-02-17 2010-03-02 Applied Materials, Inc. Contact assembly and method for electrochemical mechanical processing
US7303662B2 (en) 2000-02-17 2007-12-04 Applied Materials, Inc. Contacts for electrochemical processing
US6991528B2 (en) 2000-02-17 2006-01-31 Applied Materials, Inc. Conductive polishing article for electrochemical mechanical polishing
US7374644B2 (en) 2000-02-17 2008-05-20 Applied Materials, Inc. Conductive polishing article for electrochemical mechanical polishing
US7303462B2 (en) 2000-02-17 2007-12-04 Applied Materials, Inc. Edge bead removal by an electro polishing process
US7059948B2 (en) 2000-12-22 2006-06-13 Applied Materials Articles for polishing semiconductor substrates
US7029365B2 (en) 2000-02-17 2006-04-18 Applied Materials Inc. Pad assembly for electrochemical mechanical processing
US7344432B2 (en) 2001-04-24 2008-03-18 Applied Materials, Inc. Conductive pad with ion exchange membrane for electrochemical mechanical polishing
US7137879B2 (en) 2001-04-24 2006-11-21 Applied Materials, Inc. Conductive polishing article for electrochemical mechanical polishing
EP1759210B1 (en) * 2001-07-13 2008-12-31 Nanosphere, Inc. Method for preparing substrates having immobilized molecules and substrates
US7297553B2 (en) * 2002-05-28 2007-11-20 Nanosphere, Inc. Method for attachment of silylated molecules to glass surfaces
US7687437B2 (en) 2001-07-13 2010-03-30 Nanosphere, Inc. Method for immobilizing molecules onto surfaces
US7407668B2 (en) * 2002-01-24 2008-08-05 Boston Scimed, Inc. Medical articles having enzymatic surfaces for localized therapy
SE527054C2 (sv) * 2002-04-23 2005-12-13 Gambro Lundia Ab Förfarande för framställning av ett regioselektivt membran
DE102004008219B3 (de) * 2004-02-19 2005-10-27 Membrana Gmbh Integral asymmetrische Membran, Verfahren zu ihrer Herstellung und ihre Verwendung
US7520968B2 (en) 2004-10-05 2009-04-21 Applied Materials, Inc. Conductive pad design modification for better wafer-pad contact
US20070270523A1 (en) * 2004-11-05 2007-11-22 Kaneka Corporation Method of Modifying Blood Contact Material and Blood Contact Material Inhibited from Activating Granulocyte
US7427340B2 (en) 2005-04-08 2008-09-23 Applied Materials, Inc. Conductive pad
WO2007069983A1 (en) 2005-12-13 2007-06-21 Exthera Ab Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood
US20080135481A1 (en) * 2006-12-06 2008-06-12 General Electric Company Polyarylethernitrile hollow fiber membranes
US7977451B2 (en) * 2006-12-15 2011-07-12 General Electric Company Polyarylether membranes
US7681741B2 (en) * 2006-12-15 2010-03-23 General Electric Company Functional polyarylethers
US20110168631A1 (en) * 2006-12-15 2011-07-14 General Electric Company Methods and apparatuses for water filtration using polyarylether membranes
US7669720B2 (en) * 2006-12-15 2010-03-02 General Electric Company Functional polyarylethers
WO2008155683A1 (en) 2007-06-18 2008-12-24 Firmenich Sa Malodor counteracting compositions and method for their use
WO2008157570A2 (en) 2007-06-18 2008-12-24 Exthera Ab Device and method for restoration of the condition of blood
CN100548456C (zh) * 2007-08-29 2009-10-14 浙江大学 一种亲和性丙烯腈基共聚物超细纤维膜的制备方法和应用
US8962097B1 (en) 2007-09-07 2015-02-24 Edward Maxwell Yokley Surface properties of polymeric materials with nanoscale functional coating
US20090069790A1 (en) * 2007-09-07 2009-03-12 Edward Maxwell Yokley Surface properties of polymeric materials with nanoscale functional coating
DE102008000220A1 (de) * 2008-02-01 2009-08-13 ASCALON Gesellschaft für Innovation in der Medizintechnik m.b.H. Hohlfaser-Separationsmembranen und Verfahren zu ihrer Herstellung
US20100222489A1 (en) * 2009-02-27 2010-09-02 Jiang Dayue D Copolymer composition, membrane article, and methods thereof
JP5925693B2 (ja) 2009-12-01 2016-05-25 エクステラ・メディカル・コーポレーション 表面固定した多糖類を用いた、血液からのサイトカイン除去法
FR2960783B1 (fr) 2010-06-04 2012-07-27 Ass Pour Les Transferts De Technologies Du Mans Membrane fonctionnalisee pour chambre d'encapsulation de cellules produisant au moins une substance d'interet therapeutique et organe bioartificiel comprenant une telle membrane
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
ES2647577T3 (es) 2012-06-13 2017-12-22 Exthera Medical Corporation Uso de heparina y carbohidratos para tratar el cáncer
CN105339067A (zh) 2013-06-24 2016-02-17 艾克塞拉医疗公司 含有涂覆甘露糖的基质的血液过滤系统
EP3065796B1 (en) 2013-11-08 2020-04-15 ExThera Medical Corporation Methods for diagnosing infectious diseases using adsorption media
CN105813626B (zh) * 2013-12-09 2019-05-07 株式会社Lg生活健康 含有碳二亚胺类化合物的组合物
JP2017513636A (ja) 2014-04-24 2017-06-01 エクスセラ メディカル コーポレイション 高流量を用いて血液から細菌を除去するための方法
CA2959975A1 (en) 2014-09-22 2016-03-31 Exthera Medical Corporation Wearable hemoperfusion device
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
WO2017151797A1 (en) 2016-03-02 2017-09-08 Exthera Medical Corporation Method for treating drug intoxication
EP3680005A1 (en) 2019-01-10 2020-07-15 Gambro Lundia AB Membrane with immobilized anticoagulant and process for producing same
CN113825517A (zh) 2019-05-16 2021-12-21 艾克塞拉医疗公司 调节内皮糖萼结构的方法
EP3981505B1 (en) 2020-10-12 2024-11-27 Gambro Lundia AB Membrane with immobilized anticoagulant and process for producing same
US12655255B2 (en) * 2021-02-12 2026-06-16 Syensqo Specialty Polymers Usa, Llc Bioactive compound immobilization on sulfone polymers
CN115120787B (zh) * 2022-06-30 2023-06-23 上海翊科聚合物科技有限公司 一种血液透析复合膜制备方法及应用
CN116789966B (zh) * 2023-06-21 2025-09-12 明基生物技术(上海)有限公司 改性聚砜与中空纤维膜及其制备方法
EP4497494A1 (en) * 2023-07-24 2025-01-29 Gambro Lundia AB Sma-blended membranes for immobilizing functional molecules
CN118718155B (zh) * 2024-09-03 2025-01-17 延阳康科技服务(上海)有限公司 一种血浆吸附过滤器和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3441142A (en) * 1966-07-21 1969-04-29 Dow Chemical Co Nonthrombogenic plastic membranes
US3522346A (en) * 1968-05-31 1970-07-28 Research Corp Nonthrombogenic microcapsules
US3616935A (en) * 1970-02-05 1971-11-02 Dow Chemical Co Preparation of antithrombogenic surfaces
US3705084A (en) * 1970-03-18 1972-12-05 Monsanto Co Macroporous enzyme reactor
US4102746A (en) * 1975-08-29 1978-07-25 Amerace Corporation Immobilized proteins
US4702840A (en) * 1982-02-05 1987-10-27 Pall Corporation Charge modified polyamide membrane
SE8200751L (sv) * 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
US4906375A (en) * 1984-07-14 1990-03-06 Fresenius, Ag Asymmetrical microporous hollow fiber for hemodialysis
US4757014A (en) * 1985-11-08 1988-07-12 Minnesota Mining And Manufacturing Company Immobilization of biologically active protein on a polymeric fibrous support
GB8915974D0 (en) * 1989-07-12 1989-08-31 Gore W L & Ass Uk Hydrophilic semi-permeable ptfe membranes and their manufacture
US5096585A (en) * 1991-01-28 1992-03-17 W. R. Grace & Co.-Conn. Process for preparing protein non-adsorptive microporous polysulfone membranes
US5283186A (en) * 1991-12-31 1994-02-01 Abbott Laboratories Preparation of a compressed membrane containing immobilized biologically acting material
DE4238389A1 (de) * 1992-11-13 1994-05-19 Bayer Ag Verfahren zur Durchführung immundiagnostischer Nachweise
US5476665A (en) * 1994-04-13 1995-12-19 Minnesota Mining And Manufacturing Company Azlactone functional particles incorporated in a membrane formed by solvent phase inversion

Also Published As

Publication number Publication date
BR9406410A (pt) 1995-12-19
ATE254953T1 (de) 2003-12-15
NO931809L (no) 1994-11-21
ES2211881T3 (es) 2004-07-16
DE69433356D1 (de) 2004-01-08
US5840190A (en) 1998-11-24
DE69433356T2 (de) 2004-08-26
PT699103E (pt) 2004-04-30
NO931809D0 (no) 1993-05-19
AU672708B2 (en) 1996-10-10
FI955525A0 (fi) 1995-11-16
JPH08510166A (ja) 1996-10-29
EP0699103B1 (en) 2003-11-26
AU6816994A (en) 1994-12-12
WO1994026399A1 (en) 1994-11-24
CA2162495A1 (en) 1994-11-24
FI955525L (fi) 1995-11-16
EP0699103A1 (en) 1996-03-06
FI955525A7 (fi) 1995-11-16

Similar Documents

Publication Publication Date Title
PT699103E (pt) Membranas biocompativeis de superficie modificada
KR100263555B1 (da)
AU3506893A (en) Use of fullerenes in diagnostic and/or therapeutic agents
GR3032791T3 (en) Polysiloxane-comprising perfluoroalkyl ethers, and the preparation and use thereof
MX9704828A (es) Una pelicula encogible en agua.
ATE103189T1 (de) Chirurgisches material und verwendung des materials zur herstellung (eines teiles) einer anordnung zur verwendung in der knochenchirurgie.
ES2052871T3 (es) Preparacion de bis (3,5-di-t-butil-4-hidroxifeniltio)metano.
DE68905205D1 (de) Verwendung von igf-i zur herstellung eines praeparats fuer die behandlung und die verhuetung von nebeneffekten von hyperinsulinemia bei diabetikern behandelt mit insulin.
DE69838986D1 (de) Polypeptide, deren herstellung und verwendung
ATE211636T1 (de) Methode zum herstellen eines dentalproduktes
GR930100300A (el) Βιοεπισυναπτόμενες συν?έσεις ?εραπείας και μέ?οδοι χρήσης.
EP0525795A3 (en) Use of fluorinated polyurethanes for the treatment of films or sheets made of cellulose, graphite, mica, kaolin, leather and similar natural materials
WO1997040072A3 (en) Adam proteins and uses thereof
ZA981780B (en) The use of levobupivacaine in paediatric surgery
ATE83641T1 (de) Implantierter durchgang.
DE59610633D1 (de) Medikament, insbesondere zur modulation der immunantwort bei der bekämpfung von viren, tumoren, bakterien und parasiten
IL131084A0 (en) The use of levobupivacaine in facial surgery
NZ230155A (en) N-2,3-butadienyl-n"-substituted-triamindalkanes and alkenes, and pharmaceutical compositions
ATE169060T1 (de) Lactobacillus sake ähnliche stämme herstellung und verwendung von deren exopolysacchariden
FR2413912A1 (fr) Medicaments a base de substances d'origine foetale et leur procede preparation
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
ATE200624T1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
NO890801D0 (no) Fremgangsmaate for fremstilling av lysyloxydaseinhibitorer.
ATE209647T1 (de) Pyridiniumsalze und ihre verwendung zur bekämpfung von helicobacter-bakterien
DE69930419D1 (de) Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie